29th - 30th October, 2020

4th Annual MarketsandMarkets Next Gen Immuno-Oncology Virtual Congress (Time Zone - BRITISH SUMMER TIME(BST))

40+
Speakers
10+
Networking Hours
12
Sessions
200+
Attendees

In the past decade, many scientific breakthroughs have been achieved through research including success in recent years of cancer immunotherapy with monoclonal antibodies, cancer vaccines, adoptive cell therapy and immune-checkpoint therapy. Personalized immunotherapy with various combinations will be the next promising strategy for the future cancer treatment direction.

users

30+ experts from academia and industry will be presenting their current work in Immuno-Oncology, Latest updates on regulatory guidelines and approvals, Validation markers for tumor-derived T-cell subpopulations, NextGen T-Cell and CAR-T Cell therapy, Personalized Medicine, Biomarkers and Cancer Immunotherapy

users

Opportunity to develop long-lasting business relationships and networking opportunities with researchers, scientists, clinicians, academicians and professionals from Pharmaceutical companies, Bio-pharma companies, Universities, and Research institutes.

users

Over 20 presentations, round-tables, and panel discussions focused on the key opportunities and challenges in biomarker research, Validation methods and innovative tools in IO Discovery, Oral T-Cell Therapies for the Treatment of Cancer Patients and Discovery of novel bispecific antibody molecules to boost anti-tumor immunity

Our 4th Annual MarketsandMarkets Next Gen Immuno-Oncology Congress to be held on 29th - 30th October 2020 would address the challenges and future directions in IO research. The congress aims to bring academicians, researchers and scientists from research institutes pharmaceutical, bio-pharmaceutical and biotechnology companies to discuss the latest updates in development of ADC’s, Bispecific Antibodies, Cellular Therapy and Immune Checkpoint Inhibitors. This congress would also focus on various combination strategies, pre-clinical and translational immune-oncology developments, updates in cellular and viral therapies, vaccines development and personalized immunotherapy. Keynote presentations, Brainstorming Panel Discussions and Case studies will give the stakeholders an opportunity to discuss and understand the issues faced and come up with solutions.

WHAT TO EXPECT
Why Attend?
  • Exclusive conference to learn about antibodies, cellular therapy and immune-checkpoint research under one roof
  • Find out new case studies of immune-oncology projects in development
  • Contribute to interactive roundtables with your peers to deliberate key topics most relevant to you
  • Explore the latest platforms and technologies on the market for development
  • Discuss the best tool for your research in immune-oncology
  • Share your work and achievements with your industry peers in the Poster Sessions 
Key Highlights
  • Updates in development of monoclonal antibodies, ADC’s and Bispecific Ab’s
  • Immune Checkpoint Inhibitors and Combinations
  • Biomarkers and Cancer Vaccines
  • CAR-T cell therapy, T Cell Therapy
  • Tumor microenvironment
  • Oncolytic Viruses
  • Microbiome in Cancer Immunotherapy
CONFERENCE AGENDA
Therapeutic Antibodies and Cellular Therapy
Advances in IO
Immune Checkpoint Inhibitors and Combinations
Personalized Immunotherapy, Vaccines and Oncolytic Viral Therapy
CONFERENCE SPEAKERS
Advisors
Stefan Gluck

Stefan Gluck

Vice President
Celgene, USA

Stefan Gluck

Vice President
Celgene, USA
Sophia Karagiannis

Sophia Karagiannis

Professor, Translational Cancer Immunology and Immunotherapy
King’s College London, UK

Sophia Karagiannis

Professor, Translational Cancer Immunology and Immunotherapy
King’s College London, UK
Eugene Zhukovsky

Eugene Zhukovsky

Chief Scientific Officer
Biomunex Pharmaceuticals, France

Eugene Zhukovsky

Chief Scientific Officer
Biomunex Pharmaceuticals, France
Speakers
Bruno Tullia

Bruno Tullia

Assistant Professor
UPMC Hillman Cancer Center, USA

Bruno Tullia

Assistant Professor
UPMC Hillman Cancer Center, USA
Roy Baynes

Roy Baynes

Senior Vice President and Head, Global Clinical Development, Chief Medical Officer
Merck Research Laboratories

Roy Baynes

Senior Vice President and Head, Global Clinical Development, Chief Medical Officer
Merck Research Laboratories
Ian Pike

Ian Pike

Chief Scientific Officer
Proteome Sciences

Ian Pike

Chief Scientific Officer
Proteome Sciences
David Gilham

David Gilham

Vice President, R&D
Celyad, UK

David Gilham

Vice President, R&D
Celyad, UK
Pirouz Daftarian

Pirouz Daftarian

Senior Manager, Applications for Immunooncology and Vaccines
JSR Micro Life Sciences and MBL International

Pirouz Daftarian

Senior Manager, Applications for Immunooncology and Vaccines
JSR Micro Life Sciences and MBL International
John Maher

John Maher

Chief Scientific Officer
Leucid Bio, UK

John Maher

Chief Scientific Officer
Leucid Bio, UK
Sheeba Irshad

Sheeba Irshad

CRUK Clinician Scientist & Honorary Medical Oncologist
Guy’s Hospital, UK

Sheeba Irshad

CRUK Clinician Scientist & Honorary Medical Oncologist
Guy’s Hospital, UK
Will Arends

Will Arends

Chartered (UK) and European Patent Attorney
Marks & Clerk, UK

Will Arends

Chartered (UK) and European Patent Attorney
Marks & Clerk, UK
SPONSORS
Gold
example-image

Proteome Sciences

Silver
example-image

Miltenyi Biotec

example-image

Ultivue

Speaking Partner
example-image

PromoCell

example-image

TransCure bioServices

example-image

MBL International

example-image

HalioDx

example-image

Marks & Clerk

example-image

PHC Group

example-image

Crown Bioscience

Leading Partner
example-image

GenScript

example-image

Personalis

Primary Partner
example-image

Imaging Endpoints

example-image

Thermo Fisher Scientific

example-image

Aquila BioMedical

example-image

Horizon Discovery

Exhibition Partner
example-image

Mi-mAbs

example-image

KDBIO

example-image

Synthace

PARTNERS
Supporting Association
MabDesign

MabDesign

One Nucleus

One Nucleus

Media Partners
example-image

Technology Networks

example-image

Pharma Journalist

example-image

PharmaTutor

example-image

GEN

example-image

MedNous

example-image

Medical events guide

NEWS
PAST EVENT GALLERY